Oticon Medical news

Oticon Medical’s parent company Demant has decided to discontinue its hearing implants business.

We’re feeling the Good Vibrations for this May 3rd which marks Bone Anchored Awareness Day

First 65 dB Processor with Open Sound Experience and No Audible Feedback

We’re feeling the Good Vibrations for this May 3rd which marks Bone Anchored Awareness Day

Oticon Medical today announced that the US Food and Drug Administration (FDA) has granted premarket approval (PMA) to the company’s Neuro System.

May 3rd will be the first ever annual Bone Anchored Awareness Day.
Oticon Medical initiates this annually recurring awareness day “Good Vibrations” to celebrate bone anchored hearing as a treatment and to create more awareness about this treatment. 

Oticon Medical is pleased to have been involved in the first ever global consensus on the use of cochlear implants as the minimum standard of care for adults with bilateral severe, profound, or moderate sloping to profound hearing loss.

A recent scientific paper quantifies the benefits in terms of speech identification in quiet and in noise that Neuro 2 users experience

The Royal Highness's, Crown Prince Frederik and Crown Princess Mary have spent the last days in France in order to support the growth and position of Danish companies